Denosumab Subcutaneous and Zoster Vaccine (Recombinant)
Determining the interaction of Denosumab Subcutaneous and Zoster Vaccine (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: zoster vaccine, inactivated
Brand name: Shingrix
Synonyms: Zoster vaccine (inactivated)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Zoster vaccine inactivated
- Denosumab Subcutaneous-Zoster vaccine live
- Denosumab Subcutaneous-Zoster vaccine recombinant, adjuvanted Intramuscular
- Denosumab Subcutaneous-Zoster vaccine, live Subcutaneous
- Denosumab Subcutaneous-Zostrix
- Denosumab Subcutaneous-Zostrix (Capsaicin Cream, Gel, Liquid, and Lotion)
- Zoster Vaccine (Recombinant)-Denovo
- Zoster Vaccine (Recombinant)-Dent-O-Kain/20
- Zoster Vaccine (Recombinant)-Denti-Care Denti-Freeze Topical Anesthetic
- Zoster Vaccine (Recombinant)-DentiPatch
- Zoster Vaccine (Recombinant)-Deoxycholic acid
- Zoster Vaccine (Recombinant)-Deoxycholic acid Subcutaneous